JUN 02, 2022 7:20 PM PDT

A Direct Comparison of COVID-19 Vaccines

WRITTEN BY: Carmen Leitch

As soon as the COVID-19 pandemic hit, researchers isolated SARS-CoV-2 and began studying the virus. The information scientists obtained, such as the genetic sequence of the viral genome, was put to good use, and several vaccines were developed. Now that it's been over two years since many people were first vaccinated, researchers have also been able to study how several stack up against each other; antibody production, T cells, and B cells in recipients have been assessed for mRNA vaccines made by Pfizer-BioNTech or Moderna, a protein-based vaccine made by Novavax, and the Janssen/J&J vaccine, which uses a viral vector. All of the vaccines are meant to create antibodies against the SARS-CoV-2 spike protein, which is used by the virus to infect cells. The findings, which are the first to compare three types of vaccines made for the same pathogenic target, have been reported in Cell.

Colorized scanning electron micrograph of a cell (orange) infected with UK B.1.1.7 variant SARS-CoV-2 virus particles (green), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

"We aren't giving a vaccine scorecard," noted study co-leader and LJI Research Assistant Professor Daniela Weiskopf, Ph.D. "This kind of side-by-side analysis has never been done before with people who received different vaccines at the same time in a real life setting. Just understanding the immune responses to these vaccines will help us integrate what is successful into vaccine designs going forward."

The study found that after six months, the Moderna vaccine generated the highest level of neutralizing antibodies, followed by Pfizer-BioNTech, then Novavax. The lowest neutralizing antibody levels were triggered by the Janssen/J&J vaccine. However, the recipients of the Janssen/J&J vaccine had the highest proportion of memory B cells after six months.

All vaccines resulted in about the same levels of both memory CD4+ helper T cells and CD8+ T cells. The fewest CD8+ killer T cells were found in recipients of the Novavax vaccine. While those given Pfizer-BioNTech, Moderna, or Janssen/J&J had a more robust CD8+ response, only about 65 percent of participants still had memory CD8+ T cells after six months. The researchers noted that this immune memory might prevent infection, and while it also may not, it does stave off severe disease.

"Even if it is difficult to maintain a high level of neutralizing antibodies long term, the presence of a stable cellular immunity shows that the immune system can be reactivated very quickly, in a matter of days, if there is an infection," said study co-leader LJI Professor Alessandro Sette, Dr. Biol. Sci

The researchers also want to learn more about how booster shots may impact immune memory, and are currently investigating cases in which vaccinated people had breakthrough infections.

Sources: La Jolla Institute of Immunology, Cell

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 22, 2021
Coronavirus
Which COVID vaccine and booster are right for me?
DEC 22, 2021
Which COVID vaccine and booster are right for me?
The 2-year anniversary of the COVID-19 pandemic, which began in December 2019, recently passed. It would not be overstat ...
FEB 17, 2022
Immunology
A Post-vaccination Workout Boosts Immune Responses
FEB 17, 2022
A Post-vaccination Workout Boosts Immune Responses
  A workout after getting a vaccine for influenza or COVID-19 may provide additional immune protection, says a new ...
APR 21, 2022
Coronavirus
COVID-19 Increases Risk for Blood Clots and Bleeding Months after Infection
APR 21, 2022
COVID-19 Increases Risk for Blood Clots and Bleeding Months after Infection
A nationwide study recently reported that COVID-19 infection increases risk for a constellation of blood clot-related ev ...
JUN 11, 2022
Coronavirus
Dogs Could Be Even Better at Detecting Covid-19 Than a PCR Test
JUN 11, 2022
Dogs Could Be Even Better at Detecting Covid-19 Than a PCR Test
Dogs are amazing. And their sense of smell, well, it's pretty good, too – significantly better than our own. W ...
JUL 15, 2022
Coronavirus
The "Worst Version" of COVID-19 is Here
JUL 15, 2022
The "Worst Version" of COVID-19 is Here
Variants of SARS-CoV-2, the virus that causes COVID-19, have been continuously emerging since the start of the pandemic. ...
JUL 23, 2022
Drug Discovery & Development
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
JUL 23, 2022
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
An anti-inflammatory compound has shown promise in treating systemic inflammation and brain injury in patients with seve ...
Loading Comments...